## MOH: Molina Healthcare, Inc. - XLV: Healthcare

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.5% in lower entry zone (3.0-6.0%), top 1% cross-sectional ranking. Short-term MRS_5 (3.4%) confirms momentum alignment. Strong momentum (+4.7% 5-day acceleration). Outperforming sector by 2.3%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($160.29)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 3, Bearish: 4)

**1. Molina Healthcare schedules early-morning call to review 2025 results**
- Source: Stock Titan | 20251230T211722 | Neutral | Relevance: 100%
- Molina Healthcare, Inc. (NYSE: MOH) will release its Q4 and full-year 2025 earnings after market close on February 5, 2026. The company will host a conference call and webcast on Friday, February 6, 2026, at 8:00 a.m. Eastern Time to discuss these results. Details for accessing the teleconference and webcast replay are provided.

**2. Michael Burry strikes again: Molina Healthcare in focus this time**
- Source: TradingView â€” Track All Markets | 20251230T190824 | Bullish | Relevance: 100%
- Michael Burry, known for "The Big Short," believes Molina Healthcare (MOH) could be a takeover target in 2026, comparing its potential to Warren Buffett's Geico investment. He praises the company's strong fundamentals and Medicaid resilience, suggesting a takeover would provide a premium for shareholders. Even without a buyout, Burry and Wall Street analysts see potential for MOH shares due to attractive valuation and operational discipline.

**3. Molina Healthcare Inc. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251230T163000 | Bullish | Relevance: 100%
- Shares of Molina Healthcare Inc. (MOH) rallied 2.47% to $170.66 on a dismal trading day, outperforming the S&P 500 Index and Dow Jones Industrial Average. This marks the stock's third consecutive day of gains.

**4. Molina Healthcare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call Dates**
- Source: Barchart.com | 20251230T211722 | Neutral | Relevance: 100%
- Molina Healthcare, Inc. (NYSE: MOH) will release its fourth quarter and year-end 2025 earnings after market close on Thursday, February 5, 2026. A conference call and webcast to discuss these results will be held on Friday, February 6, 2026, at 8:00 a.m. Eastern Time. Details for accessing the call and a subsequent replay are provided.

**5. Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Shareholders to Inquire about Securities Investigation**
- Source: WRIC ABC 8News | 20251228T210813 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (NYSE: MOH) regarding corporate wrongdoing. The firm encourages shareholders who purchased Molina securities prior to February 5, 2025, and still hold them, to contact them for more information and to assist in the investigation. The investigation seeks to determine if Molina and its officers or directors engaged in misconduct.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (9.4%): bears positioning against stock.
2. Long-term trend broken: trading 24.3% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.54 signals overvaluation risk, limited margin of safety. Forward P/E 10.4x attractive for 18% earnings growth. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.2B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 9.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.54 |
| Forward P/E | 10.4 |
| Current P/E | 12.3 |
| YoY Growth | 18.1% |
| EPS Direction | None |

### Technicals

MRS_10 strengthening from -1.3% to 3.5% (+4.7% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 98th percentile. MRS_5 at 3.4% confirms short-term momentum alignment. Below SMA200 (0.76x), long-term trend not supportive. MACD histogram positive (0.89), confirming momentum. OFD pattern: -DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.45% (CS: 99) | Strong |
| RSI_14 | 67.4 | Neutral |
| MACD Histogram | 0.89 | Bullish |
| vs SMA20 | 1.062x | Above |
| vs SMA50 | 1.095x | Above |
| vs SMA200 | 0.757x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $170.67
- **Stop Loss:** $160.29 (6.1% risk)
- **Target:** $186.24 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 127
- **Position Value:** $21,675.09
- **Portfolio %:** 21.68%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*